![Jeegar Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeegar Patel
Hoofd Techniek/Wetenschap/O&O bij
EVOMMUNE, INC.
Vermogen: 522 034 $ op 31-07-2026
Profiel
Jeegar Patel is currently Chief Scientific Officer at Evommune, Inc. since 2022.
Formerly, Dr. Patel was Senior VP-Research & Nonclinical Development at Kadmon Holdings, Inc. Education includes an undergraduate degree from the University of the Sciences in Philadelphia and a doctorate from Drexel University College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EVOMMUNE, INC. 0,13% | 22-06-2026 | 46.403 ( 0,13% ) | 522 034 $ | 31-07-2026 |
Actieve functies van Jeegar Patel
| Bedrijven | Functie | Begin |
|---|---|---|
| EVOMMUNE, INC. | Hoofd Techniek/Wetenschap/O&O | 03-10-2022 |
Eerdere bekende functies van Jeegar Patel
| Bedrijven | Functie | Einde |
|---|---|---|
| KADMON HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jeegar Patel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
17
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
University of the Sciences in Philadelphia
 University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
